cabotegravir
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
3 FDA-registered drug labelers
Aurobindo Pharma Limited
Cipla Ltd.
Glaxo Wellcome Manufacturing Pte. Ltd
Why It Matters
Sectors
Health
Downstream UsesNo data available
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS1051375-10-0
PubChem CID54713659
DTXSIDDTXSID50146982
FormulaC19H17F2N3O5
Mol. Weight405.4 g/mol
SMILESCC1COC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O
Data Sources
547136592026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/cabotegravir/cids/JSON
Archive: data/sources/pubchem_name/cabotegravir.json
CAS 1051375-10-02026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json